A DTAP–IPV//PRP~T VACCINE: A REVIEW OF 16 YEARS’ CLINICAL EXPERIENCE

A DTAP–IPV//PRP~T VACCINE: A REVIEW OF 16 YEARS’ CLINICAL EXPERIENCE

Owing to their low reactogenicity, confirmed efficacy and availability in combination vaccines, acellular pertussis (aP)-inactivated poliovirus (IPV) combined vaccines are now included in various national immunization programs worldwide. We provide an overview of 16 years of clinical experience with...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Stanley A. Plotkin, Johannes Liese, Shabir A. Madhi, Esteban Ortiz
Materialtyp: Artikel
Språk:English
Publicerad: "Paediatrician" Publishers LLC 2012-01-01
Serie:Вопросы современной педиатрии
Ämnen:
efficacy
immunogenicity
pediatric combined vaccine
pentacomponent pentaxim
public health
safety
Länkar:https://vsp.spr-journal.ru/jour/article/view/507

Internet

https://vsp.spr-journal.ru/jour/article/view/507

Liknande verk